Premenstrual syndrome in adolescents: diagnosis and treatment.
It is estimated that 60-80% of menstruating women experience some degree of premenstrual symptomatology; however the diagnosis of premenstrual syndrome (PMS) or premenstrual dysphoric disorder (PMDD) is assigned, using defined criteria, to those women whose lives are significantly affected by moderate to severe symptoms. Though these diagnoses are not frequently made in the adolescent group, the literature suggests that a similar proportion of teens would also meet criteria for PMS/PMDD. In adolescents, treatment should begin with education and lifestyle changes; however, many of the treatments used commonly in adults can also be employed safely in severe adolescent cases.
Rapkin
Andrea J
AJ
Department of Obstetrics and Gynecology, David Geffen School of Medicine at UCLA, Los Angeles, CA 90095, USA. arapkin@mednet.ucla.edu
Mikacich
Judith A
JA
D000293:Adolescent; D000736:Androstenes / Q000627:therapeutic use; D002118:Calcium / Q000627:therapeutic use; D005260:Female; D006801:Humans; D019964:Mood Disorders / Q000175:diagnosis / Q000188:drug therapy / Q000209:etiology; D010353:Patient Education as Topic; D011293:Premenstrual Syndrome / Q000175:diagnosis* / Q000188:drug therapy*; D017367:Selective Serotonin Reuptake Inhibitors / Q000627:therapeutic use; D013148:Spironolactone / Q000627:therapeutic use
D000736:Androstenes; D002118:Calcium; D017367:Selective Serotonin Reuptake Inhibitors; D013148:Spironolactone; C035144:drospirenone